4-methoxyamphetamine has been researched along with Iron Overload in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koussa, S; Maakaron, JE; Matta, BN; Musallam, KM; Taher, AT | 1 |
Berdoukas, V; Berdoussi, E; Chouliaras, G; Kattamis, C; Ladis, V; Moraitis, P; Zannikos, K | 1 |
Berdoukas, V; Chatziliami, A; Chouliaras, G; Fragodimitri, C; Karabatsos, F; Karagiorga-Lagana, M; Kattamis, A; Ladis, V; Youssef, J | 1 |
3 other study(ies) available for 4-methoxyamphetamine and Iron Overload
Article | Year |
---|---|
A killer revealed: 10-year experience with beta-thalassemia intermedia.
Topics: Adolescent; Adult; Aged; Anemia; beta-Thalassemia; Child; Child, Preschool; Cross-Sectional Studies; Death; Heart Diseases; Humans; Infant; Iron Overload; Lebanon; Male; Middle Aged; Risk Factors; Young Adult | 2014 |
Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit.
Topics: Adolescent; Adult; Age Factors; Benzoates; beta-Thalassemia; Child; Death; Deferasirox; Deferiprone; Deferoxamine; Female; Greece; Heart Diseases; Humans; Iron; Iron Chelating Agents; Iron Overload; Magnetic Resonance Spectroscopy; Male; Pyridones; Transfusion Reaction; Treatment Outcome; Triazoles; Young Adult | 2010 |
Impact of magnetic resonance imaging on cardiac mortality in thalassemia major.
Topics: Adult; beta-Thalassemia; Blood Transfusion; Chelating Agents; Death; Heart; Humans; Iron; Iron Overload; Magnetic Resonance Imaging; Myocardium; Proportional Hazards Models; Regression Analysis; Risk; Treatment Outcome | 2011 |